RenovoRx, Inc. - stock earnings
RNXT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.4 million USD | ? USD |
| 2023Q2 | -2.3 million USD | ? USD |
| 2023Q1 | -3.3 million USD | ? USD |
| 2022Q4 | -2.1 million USD | ? USD |
| 2022Q3 | -2.1 million USD | ? USD |
| 2022Q2 | -2.6 million USD | ? USD |
| 2022Q1 | -3.0 million USD | ? USD |
| 2021Q4 | -2.4 million USD | ? USD |
| 2021Q3 | -1.5 million USD | ? USD |
| 2021Q2 | -1.3 million USD | ? USD |
| 2021Q1 | -1.1 million USD | ? USD |
| 2020Q4 | -878000 USD | ? USD |
| 2020Q3 | -1.1 million USD | ? USD |
| 2020Q2 | -773000 USD | ? USD |
| 2020Q1 | -1.1 million USD | ? USD |
RNXT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.2 million USD | ? USD |
| 2022 | -9.8 million USD | ? USD |
| 2021 | -7.1 million USD | ? USD |
| 2020 | -4.4 million USD | ? USD |
| 2019 | -3.8 million USD | ? USD |
RNXT
Price: $1.24
52 week price:
Earnings Per Share: -0.99 USD
P/E Ratio: -1.67
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 20500
Market Capitalization: 20.6 million